The Clarity BioSolutions sample preparation portfolio is composed of unique solid phase extraction chemistries packed in 96-well plate and cartridge formats designed to efficiently and effectively purify oligonucleotides.
Prior to LC-MS analysis, therapeutic oligonucleotides must be isolated from interferences such as salts, sugars, large proteins, and genomic DNA. Using a mixed-mode solid phase extraction (SPE) sorbent in conjunction with carefully formulated buffers, Clarity OTX consistently delivers high recoveries.
Clarity Products | Particle Support | Bonded Phase | Particle Shape/Size (μm) | Pore Size(Å) | Surface Area (m2/g) |
---|---|---|---|---|---|
Polymer (surface modified PSDVB) |
Mixed-mode anion exchanger |
33 |
85 |
800 |
|
Polymer (PSDVB) |
Hydrophilic polymer coating |
35 |
500 |
300 |
|
Silica |
C18 |
55 |
140 |
300 |
Clarity OTX and Clarity QSP are patented by Phenomenex. U.S. Patent No. 7,119,145